Clinical Research Center in Hungary Purchases ALPHADAS for New Phase I Unit
CRU Hungary Selects ALPHADAS to Help Deliver Next Level of Service to Sponsors
CONSHOHOCKEN, PA - (BUSINESS WIRE) – June 13, 2014 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Clinical Research Units Hungary (“CRU Hungary”) has purchased the entire ALPHADAS® clinical trials software solution suite for a new Phase I facility being constructed in eastern Europe.
CRU Hungary is a privately owned hospital-based clinical research center that specializes in conducting outpatient and inpatient Phase II through IV clinical trials involving pharmaceutical, biological and medical device products. CRU Hungary serves sponsor companies and contract research organizations by conducting clinical studies within 5 different locations throughout Hungary.
“CRU Hungary is completely focused on responding quickly to the research needs of its sponsors, and it is our privilege to be supporting them as they bring their new Phase I unit on-line,” states Mark Cusack, VP Business Development at Instem Clinical. “It is reassuring to our entire market strategy to see yet another client such as CRU Hungary choosing ALPHADAS to be an integral part of delivering operational and data management excellence to their clients.”
Instem’s ALPHADAS software solution suite is a proactive eSource clinical research and early phase trials system that is mobile, schedule-driven, and provides real-time bedside or station based direct data capture that virtually eliminates paper-based data.
ALPHADAS used by organizations across four continents to improve client efficiencies, reduce trial times and provide real-time data to sponsors.
“Beyond the comprehensive features and straightforward intuitive functionality, it was our visit to an ALPHADAS user site that cemented our decision to go with Instem Clinical,” comments Dr Peter Kovacs at CRU Hungary. “Rather than a vendor, we were really looking to select a partner that could align with our mission of providing our clients with quality data and optimal study speed. The staff at Instem Clinical are true hands-on practitioners in our field, and they are poised to ensure that their ALPHADAS technology delivers superior results with high quality standards.”
Key Facts
- Entire ALPHADAS software suite chosen by CRU Hungary
- ALPHADAS to be deployed at newly constructed Phase I unit in Hungary
- ALPHADAS seen as key component for delivering high sponsor service levels
- Instem chosen for deployment and customer satisfaction record
About Clinical Research Units Hungary
Clinical Research Units Hungary (CRU Hungary Ltd.) is a privately owned Hospital-based Clinical Research Center that specializes in conducting outpatient and inpatient Phase II through IV clinical trials involving Pharmaceutical, Biological and Medical Device products.
More about CRU Hungary can be found at www.cruhungary.com
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Press Contacts:
Instem
Gary Mitchell (US HQ)
gary.mitchell@instem.com
Tel: 610-941-0990
Julie Jones (UK HQ)
julie.jones@instem.com
Tel: +44 (0) 1785 825600
